Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down News and commentary from the endocrinology world Nov 05, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia Also in TTHealthWatch: best medications for opioid use disorder Oct 26, 2024 podcast
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis Large observational study suggests further research is warranted Oct 24, 2024
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients Findings leave researcher "concerned" Oct 23, 2024
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids News and commentary from the endocrinology world Oct 22, 2024
No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
Serious Battery Issue Prompts Medtronic Insulin Pump Recall Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer News and commentary from the endocrinology world Oct 15, 2024
CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Disease Plus: nalbuphine for IPF cough and AI for reducing lung allograft discards Oct 14, 2024
Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia News and commentary from the endocrinology world Oct 08, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D News and commentary from the endocrinology world Oct 01, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Risk Also in TTHealthWatch: AACR report on cancer Sep 28, 2024 podcast
GLP-1 Agent May Hold Opioid Use Disorder Benefit Researchers highlight semaglutide's potential value for preventing overdoses Sep 26, 2024
One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Puberty News and commentary from the endocrinology world Sep 24, 2024
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices The three companies process about 80% of prescriptions in the U.S. Sep 20, 2024
FDA Rejects NK1R Antagonist for Gastroparesis Drugmaker none-too-pleased with agency's request for additional studies Sep 19, 2024
Coffee and Heart, Metabolic Risks; What Drives Doctors Away; Ozempic for $100? Health news and commentary gathered by staff Sep 18, 2024
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists? Researcher discusses weight outcomes for those taking semaglutide or liraglutide Sep 16, 2024 video
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
8-Hour Eating Window Improved Glycemic Control, Small Study Shows Three-day intervention boosted time spent in normal glucose range Sep 13, 2024
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play Regulators will need to closely watch this new frontier Sep 13, 2024
Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease Relationship was mediated by comorbid dyslipidemia Sep 11, 2024
Steroid Use Tied to Diabetes; Suicide Rates Climbing; Legionnaire's Death Toll Rises Health news and commentary gathered by staff Sep 11, 2024
Weekly Insulin Efsitora Noninferior to Daily Degludec in Type 1, Type 2 Diabetes But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use Sep 10, 2024
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win News and commentary from the endocrinology world Sep 09, 2024
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics News and commentary from the endocrinology world Sep 03, 2024
GLP-1 Agonists May Offer Protection Against Glaucoma in Type 2 Diabetes Significant reductions in glaucoma, ocular hypertension, prescriptions versus metformin Aug 28, 2024
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available News and commentary from the endocrinology world Aug 27, 2024
FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetes SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System Aug 27, 2024
Matthew Perry's Doc Reopens Clinic; Trump's Medical Records; Drug Cuts Diabetes Risk Health news and commentary gathered by staff Aug 21, 2024
